The protein expression of bcl-2, bax, Fas/Apo-1 in acute myeloid leukemia

Abstract

The protein expression of bcl-2, bax, Fas/Apo-1 in 19 cases of acute myeloid leukemia (AMD were investigated by Western blot and ApAAp techniques. High expression of bcl-2 protein was found in most of the AML cases, and some of the cases expressed Fas/Apo-1 and bax. High expression of bcl-2 protein was associated with a bad clinical prognosis and a poor response after intensive chemotherapy. Bax seemed to coexpress with bcl-2 and so appeared to be a bad prognostic factor instead of a good one. The expression of Fas/Apo-1 was inversely correlated with bcl-2 and seemed to be a good prognostic factor which may reflect the relative homeostasis of apoptotic pathway. It is concluded that apoptosis-induced pathways in AML often exhibit disturbance features. Coregulation of bcl-2, Bax and Fas/Apo-1 genes formed the apoptosis-induced pathway, which is the biological factor affecting response to chemotherapy.

Keywords

apoptosis / bcl-2 / FaslApo-1 / bax / AML

References

[1] SachsL, LotemJ. Control of programmed cell death in normal and leukemia cells. New implications for therapy. Blood, 1993, 38: 15-15

[2] OltvaiI N, MillimenC L, KorsmeyerS J. Bcl-2 heterodimerizesin vivo with a conserved homolog bax, that accelerates programmed cell death. Cell, 1993, 74: 609-609

[3] NegataS, GolsteinP. The FAS death factor. Science, 1995, 267: 1994-1994

[4] DeliaD, AielloA, SoligoD, et al.. Bcl-2 protooncogene expression in normal and neoplastic human myeloid cells. Leukemia, 1995, 9: 1191-1191

[5] Miyashita T, Kitada S, Krajewskiet al. The bcl-2 protein regulates the half-life of p21-bax. Blood, 1995, 15(suppl): 5326a

[6] MeijerinkJ P, SemtersT F, StöetjesA W, et al.. Bax mutations in cell lines derived from hematological malignancies. Leukemia, 1995, 9: 1828-1828